Target intelligence / Profile preview

Ubiquitin conjugating enzyme E2 S pseudogene 1 (UBE2SP1)

Target
UBE2SP1
Molecular classification
Other
01

Overview

UBE2SP1 is annotated as a pseudogene, meaning it is a non-functional genomic DNA sequence related to the functional ubiquitin-conjugating enzyme E2 S (UBE2S). Unlike the parent gene, UBE2S, which encodes a functional E2 enzyme with clear roles in the ubiquitin-proteasome system and cell cycle regulation, UBE2SP1 does not code for an active protein and has no known biological functions or therapeutic relevance.

Other names
UBE2S pseudogene 1UBE2SP1Ubiquitin-conjugating enzyme E2 S pseudogene 1

Beyond the preview

Go deeper on Ubiquitin conjugating enzyme E2 S pseudogene 1 (UBE2SP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin conjugating enzyme E2 S pseudogene 1 (UBE2SP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call